Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. S-3 Offering Registration Statement
  2. 8-K Event Material agreement · Executive or director change
  3. 8-K Event Material agreement · New debt or obligation
  4. 10-Q Report Quarterly Report
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 8-K Event Bylaws or fiscal year change
  8. 10-Q Report Quarterly Report
  9. 8-K Event Executive or director change
  10. 10-K/A Report 10-K/A
  11. 10-K Report Annual Report
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 4 Insider Changes in Ownership
  14. 4/A Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 3 Insider Initial Statement of Ownership

Page 27 of 31 · 604 filings